VCI Global Teases ‘Project QG': Sovereign AI and Encrypted Data Monetization Platform Poised to Reshape the Global AI Infrastructure Landscape
KUALA LUMPUR, Malaysia, May 29, 2025 (GLOBE NEWSWIRE) -- VCI Global Limited (NASDAQ: VCIG) ('VCI Global' or the 'Company'), a diversified global holding company, today announced the stealth development of Project QG, a next-generation infrastructure platform designed to enable sovereign AI deployment and unlock a new era of encrypted data monetization for governments and institutions.
Now entering the proof-of-concept stage, Project QG fuses AI-driven hardware encryption, zero-trust computing, and blockchain validation to deliver what VCI Global believes could become a foundational layer for the future of AI and data sovereignty.
Redefining Data Control and Value Creation in the AI Era
A vast majority of institutional and national datasets remain underutilized due to regulatory risks, privacy concerns, and the lack of secure AI infrastructure. According to Grand View Research, the global artificial intelligence (AI) market is projected to exceed US$1.8 trillion by 2030, driven by rapid enterprise adoption and the growth of AI-native infrastructure.
The cybersecurity and data protection market is also gaining momentum. Markets and Markets forecasts it to reach approximately US$298.5 billion by 2028. Meanwhile, Deloitte Insights notes that enterprises are increasingly monetizing proprietary data and software assets to generate new revenue streams. Industry analysts describe enterprise and sovereign data monetization as the next frontier in digital value creation, with significant upside expected privacy-first AI infrastructure continues to mature.
Project QG: Built for Institutions That Cannot Afford to Compromise
Governments, regulators, and data-rich enterprises increasingly require sovereign-ready infrastructure to maintain control, comply with data localization laws, and generate value, without relinquishing custody of their information.
Project QG is built specifically for this market, positioning VCI Global at the forefront of the convergence between AI, cybersecurity, and sovereign data economics.
VCI Global is currently engaging selected institutional stakeholders for early proof-of-concept pilots. The full platform is slated for launch in Q3 2025, with additional technical and strategic details to be revealed in the months ahead.
'We're building a platform for an AI-driven world where data remains protected, sovereign, and monetizable. With Project QG, we aim to solve one of the biggest structural challenges of the digital age, unlock value from sensitive data without ever compromising its integrity or ownership,' said Dato' Victor Hoo, Group Executive Chairman and Chief Executive Officer of VCI Global.
About VCI Global Limited
VCI Global is a diversified global holding company with a strategic focus on AI & Robotics, Fintech, Cybersecurity, Renewable Energy, and Capital Market Consultancy. With a strong presence in Asia, Europe, and the United States, VCI Global is committed to driving technological innovation, sustainable growth, and financial excellence across multiple industries.
For more information on the Company, please log on to https://v-capital.co/.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements that are subject to various risks and uncertainties. Such statements include statements regarding the Company's ability to grow its business and other statements that are not historical facts, including statements which may be accompanied by the words 'intends,' 'may,' 'will,' 'plans,' 'expects,' 'anticipates,' 'projects,' 'predicts,' 'estimates,' 'aims,' 'believes,' 'hopes,' 'potential' or similar words. These forward-looking statements are based only on our current beliefs, expectations, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of our control. Therefore, you should not rely on any of these forward-looking statements. Actual results could differ materially from those described in these forward-looking statements due to certain factors, including without limitation, the Company's ability to achieve profitable operations, customer acceptance of new products, the effects of the spread of coronavirus (COVID-19) and future measures taken by authorities in the countries wherein the Company has supply chain partners, the demand for the Company's products and the Company's customers' economic condition, the impact of competitive products and pricing, successfully managing and, general economic conditions and other risk factors detailed in the Company's filings with the United States Securities and Exchange Commission ('SEC'). The forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake any responsibility to update the forward-looking statements in this release, except in accordance with applicable law.
CONTACT INFORMATION:
For media queries, please contact:
VCI GLOBAL LIMITED
[email protected]
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Stock market today: Dow, S&P 500 and Nasdaq futures rise as stocks set to end June with a bang
US stock futures edged higher Sunday evening, setting up the major indexes for more records to end one of the most volatile first halves of a year in recent memory. Futures tied to the Dow Jones Industrial Average (YM=F) rose around 0.5%. Contracts on the S&P 500 (ES=F) gained 0.2%, and Nasdaq 100 (NQ=F) futures ticked up 0.3%. Several of Trump's economic agenda items are in focus this week. A July 9 deadline looms before the possible resumption of Trump's unilateral tariffs, which Trump on Sunday said he didn't think he'd "need to" extend. On the trade front, India has extended its Washington visit to finalize a deal. Administration officials last week confirmed a trade framework with China was in place, bolstering investor sentiment despite a late-Friday dip triggered by Trump's abrupt halt to talks with Canada, citing its digital tax policy. Meanwhile, market watchers are closely following Senate negotiations over Trump's proposed $4.5 trillion tax cut bill. The measure, which passed a procedural vote Saturday, could face a tough path in the House. The Congressional Budget Office estimates it would add $3.3 trillion to the deficit over a decade. For the market, June's gains have been substantial, fueled by optimism surrounding global trade and easing fears over tariffs. The S&P 500 (^GSPC) is up over 4%, the Nasdaq Composite (^IXIC) has surged over 5.5%, and the Dow (^DJI) has climbed 3.5%. On Friday, all three major indexes closed higher, with the S&P and Nasdaq reaching new record highs for the first time since February — the start of the year's tariff-fueled stock swings. All three major indexes are up at least 3% so far this year. Looking ahead, investors will monitor key Chinese PMI data due Monday to gauge how the ongoing trade war is affecting Asia's largest economy. Despite lingering uncertainties, the broader market remains upbeat heading into the new quarter and second half.
Bloomberg
2 hours ago
- Bloomberg
China's Envoy Urges Australia to Resist US Pressure on Military Spending
China's envoy to Canberra urged Australia not to be 'incited' by NATO's support for US demands to sharply raise defense spending and instead cooperate with Beijing to resolve regional disputes. Ambassador Xiao Qian, in an opinion article published in The Australian newspaper Monday, wrote that both Australia and China rely on the same trade routes and have a major stake in safeguarding maritime security. He emphasized their roles as key trade partners with 'highly complementary' economies.
Yahoo
2 hours ago
- Yahoo
Portage Biotech Regains Full Compliance with Nasdaq Continued Listing Requirements
DOVER, Del., June 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. ('Portage' or the 'Company') (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands ('Portage'), announced today that on June 24, 2025, the Company received formal notice from The Nasdaq Stock Market LLC that the Company has evidenced compliance with all applicable requirements for continued listing on The Nasdaq Capital Market. About Portage BiotechPortage Biotech is a clinical-stage immuno-oncology company advancing a pipeline of novel biologics to transform the immune system's ability to fight cancer. For more information, visit Forward-Looking StatementsAll statements in this news release, other than statements of historical facts, including without limitation, statements regarding the Company's business strategy, plans and objectives of management for future operations and those statements preceded by, followed by or that otherwise include the words 'believe,' 'expects,' 'anticipates,' 'intends,' 'estimates,' 'will,' 'may,' 'plans,' 'potential,' 'continues,' or similar expressions or variations on such expressions are forward-looking statements. As a result, forward-looking statements are subject to certain risks and uncertainties, including, but not limited to: the risk that the Company may not secure financing, the uncertainty of the Company's ability to continue as a going concern, scientific results may not be as expected, and other factors set forth in 'Item 3 - Key Information-Risk Factors' in the Company's Annual Report on Form 20-F for the year ended March 31, 2024 and 'Business Environment – Risk Factors' in the Company's Management's Discussion and Analysis for the Three and Six Months ended September 30, 2024, filed as Exhibit 99.2 to the Company's Form 6-K. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, undue reliance should not be placed on them as actual results may differ materially from these forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof, and the Company undertakes no obligation to update publicly or revise any forward-looking statements or information, except as required by law. For More Information:Portage BiotechAlexander Pickett, Chief Executive Officerir@ while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
